Simpson Thacher Represents Initial Purchasers in $1.5 Billion Notes Offering by Roche
11.01.16
This is only gets display when printing
The Firm recently represented Barclays Capital Inc., Citigroup Global Markets Inc. and Santander Investment Securities Inc. as joint bookrunners for an offering by Roche Holdings, Inc. of $850 million 2.375% Notes due 2027 and $650 million 1.75% Notes due 2022, which are guaranteed by Roche Holding Ltd. The offering was conducted in reliance upon Rule 144A and Regulation S under the Securities Act of 1933.
The Roche Group is a leading international research-focused healthcare group which is active in more than 100 countries. Based on 2015 sales, the Roche Group was among the world’s largest producers of pharmaceuticals and was the world’s leading supplier of in vitro diagnostics.
The Simpson Thacher team for the offering included Mark Brod, Paula Querol and Anna Pollak (Capital Markets); Amber Harezlak (Intellectual Property); Jon Cantor and Michelle Goldring (Tax); Michael Isby (Environmental); and Jennie Getsin (Blue Sky).